Global Lab On A Chip Market
市场规模(十亿美元)
CAGR : %
Forecast Period |
2022 –2029 |
Market Size (Base Year) |
USD 6.29 Billion |
Market Size (Forecast Year) |
USD 13.05 Billion |
CAGR |
|
Major Markets Players |
全球芯片实验室市场,按产品(仪器、试剂和耗材、软件和其他)、技术(微阵列、微流体、组织生物芯片和其他)、应用(基因组学、蛋白质组学、即时诊断、药物发现和其他)、最终用途(医院和诊所、生物技术和制药公司、法医实验室、诊断中心和学术及研究机构)划分 – 行业趋势和预测至 2029 年
市场分析和规模
芯片实验室 (LoC) 将多种类型的分析(例如化学合成、生化活动和 DNA 测序)整合到一个芯片上。这些生化程序的小型化和优化提高了诊断速度和成本效率。此外,LoC 是一种能够将单个或多个实验室任务简化为芯片格式的设备,芯片尺寸从几平方厘米到几毫米不等。电子、流体学、光学和生物传感器都集成在 LoC 中。
Data Bridge Market Research 分析认为,2021 年芯片实验室市场规模为 62.9 亿美元,到 2029 年将飙升至 130.5 亿美元,预计在 2022 年至 2029 年的预测期内复合年增长率为 9.55%。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外,Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。
报告范围和市场细分
报告指标 |
细节 |
预测期 |
2022 至 2029 年 |
基准年 |
2021 |
历史岁月 |
2020(可定制为 2014 - 2019) |
定量单位 |
收入(单位:十亿美元)、销量(单位:台)、定价(美元) |
涵盖的领域 |
产品(仪器、试剂和耗材、软件及其他)、技术(微阵列、微流体、组织生物芯片及其他)、应用(基因组学、蛋白质组学、即时诊断、药物研发及其他)、最终用途(医院和诊所、生物技术和制药公司、法医实验室、诊断中心和学术及研究机构) |
覆盖国家 |
北美洲的美国、加拿大和墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲其他地区 |
涵盖的市场参与者 |
Siemens (Germany), Abaxis (U.S), Danaher (U.S), Thermo Fisher Scientific Inc. (U.S), F. Hoffmann-La Roche Ltd (Switzerland), Abbott (U.S), Bio-Rad Laboratories Inc. (U.S), BD (U.S), PerkinElmer Inc. (U.S), Agilent Technologies Inc. (U.S) |
Market Opportunities |
|
Market Definition
The lab-on-a-chip market is a miniature device that combines several laboratory analysis procedures into a single chip. Lap-on-chip technology is used for biochemical detection, DNA sequencing, and other applications. Chips can be as small as a few square centimeters in size and are capable of handling extremely small fluid quantities.
Lab-On-A-Chip Market Dynamics
Drivers
- Advantages of lab-on-a-chip technology
LoC technology include excellent assay sensitivity, parallelization, ergonomics, waste minimization, and others. This technology is primarily driven by the medical profession for the identification of various diseases, which aids in sample handling, provides accurate findings in a short amount of time, and serves as a market growth driver. Furthermore, in the forecast period of 2022-2029, the rise in demand for small devices, research on biosensors and biomarkers, fabrication technology, and economic feasibility will provide new opportunities for the lab-on-a-chip market.
- Rise in the chronic diseases
The integration of various disciplines and the downsizing of laboratory procedures are the hallmarks of lab-on-a-chip systems. The high level of integration required to develop LOC devices is expanding into other parts of healthcare like stem cell, drug delivery, synthetic biology, and environmental monitoring. Globally, chronic diseases are on the rise. Other factors contributing to a constant growth in frequent and costly long-term health problems include a rapidly growing global geriatric population and changes in societal behaviour. Other important factors driving the lab-on-a-chip market's growth include the use of lab-on-a-chip in the diagnosis of chronic diseases and infections.
- Usage of LoC
LoC is gaining popularity in the medical area for diagnosing various infections and disorders, including HIV infections and chronic sickness, as well as botany. This is projected to propel the market forward. Because of advantages like easy portability, automated sample processing, and re-configurability, LoC devices are in great demand. Because they deliver fast and on-time diagnosis results, LoC devices are ideal for point-of-care diagnosis.
Opportunities
Due to rising investment in research and development in pharmaceuticals, life sciences, and personalised medicine, the global lab-on-a-chip market is gaining traction. In addition, various microfluidic device makers are forming partnerships or collaborations to develop more unique lab-on-a-chip applications, propelling the industry forward. Future market growth will be fuelled by technological advancements and research into LOC miniaturisation. There are many benefits of microfluidic technologies, growing demand for diagnostics, rise in R&D investments in emerging economies, and increase in global population will provide lucrative opportunities for growth for the lab-on-chip market globally.
Restraints/Challenges
The high initial purchasing cost with lack of awareness regarding lab-on-a-chip devices among the middle income countries will act as a restrain and further challenge the growth of the lab-on-a-chip market in the forecast period mentioned above.
This lab-on-a-chip market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the lab-on-a-chip market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Lab- On-A-Chip Market
The COVID-19 pandemic had a good impact on the lab-on-a-chip market, as it has raised the focus on the creation of less time-consuming diagnostic kits, and the use of the lab-on-a-chip approach in pharmaceutical R&D has expanded. Veredus Laboratories, a Singapore-based molecular diagnostics company, recently revealed the commercial availability of a portable lab-on-a-chip diagnostic tool for detecting and distinguishing 2019-nCoV, SARS CoV, and MERS-CoV. As a result, the VereCoV detection kit combines PCR and microarray technology to give high specificity, sensitivity, and a 2-hour turnaround time. As a result, health-care facilities are time-saving diagnostic techniques.
Recent Development
- In June 2020, ImmuSAFE is a lab-based biochip test that leverages Sengenics' unique KREX protein folding technology. It is a multi-antigen COVID-19 biochip test. ImmuSAFE allows researchers to identify target epitopes, titres, and Ig class/sub-class (IgG, IgA, IgM; IgG1-4) of antibodies produced at various stages of COVID-19 infection, including disease development, initial exposure, and post-recovery to post-vaccination.
Global Lab- On-A-Chip Market Scope
芯片实验室市场根据产品类型、技术、应用和最终用户进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场,并为用户提供有价值的市场概览和市场洞察,帮助他们做出战略决策,确定核心市场应用。
产品类型
- 软件
- 试剂和耗材
- 仪器
技术
- 微阵列
- 微流体
应用
- 蛋白质组学
- 基因组学
- 药物研发
- 诊断
终端用户
- 诊断实验室
- 医院
- 生物科技及制药公司
- 学术及研究机构
芯片实验室市场区域分析/见解
对芯片实验室市场进行了分析,并按国家、产品类型、技术、应用和最终用户提供了市场规模见解和趋势。
芯片实验室市场报告涵盖的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。
北美在全球芯片实验室市场占据主导地位。
由于人口增长导致病毒性疾病患病率上升,亚太地区成为全球芯片实验室市场增长最快的地区。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外,在提供国家数据的预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
竞争格局和片上实验室市场份额分析
芯片实验室市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对芯片实验室市场的关注有关。
芯片实验室市场的一些主要参与者包括:
- 西门子(德国)
- Abaxis(美国)
- 丹纳赫(美国)
- 赛默飞世尔科技公司(美国)
- F. Hoffmann-La Roche Ltd(瑞士)
- 雅培(美国)
- Bio-Rad Laboratories Inc.(美国)
- BD(美国)
- PerkinElmer Inc.(美国)
- 安捷伦科技公司(美国)
- IDEX(美国)
- 标准 BioTools(美国)
- 贝克曼库尔特公司(美国)
- Illumina 公司(美国)
- LabSmith(美国)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.